Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 79.31% vs -67.42% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 66.48% vs 93.51% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 11.98% vs 58.76% in Mar 2024
Compare Balance Sheet Results of Shelter Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
11.56
13.95
-2.39
-17.13%
Share Warrants & Outstandings
Total Reserve
31.16
9.11
22.05
242.04%
Shareholder's Funds
42.72
23.06
19.66
85.26%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.93
0.00
0.93
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.93
0.00
0.93
0.00%
Deferred Tax Assets / Liabilities
-0.03
0.09
-0.12
-133.33%
Other Long Term Liabilities
0.05
0.00
0.05
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.95
0.09
0.86
955.56%
Current Liabilities
Trade Payables
1.25
1.39
-0.14
-10.07%
Other Current Liabilities
3.27
0.61
2.66
436.07%
Short Term Borrowings
0.11
2.57
-2.46
-95.72%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
4.63
4.57
0.06
1.31%
Total Liabilities
48.30
27.73
20.57
74.18%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
8.36
9.39
-1.03
-10.97%
Less: Accumulated Depreciation
2.39
8.11
-5.72
-70.53%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
5.96
1.28
4.68
365.62%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
1.57
-1.57
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.68
0.00
0.68
0.00%
Long Term Loans & Advances
8.39
5.06
3.33
65.81%
Other Non Current Assets
0.00
7.26
-7.26
-100.00%
Total Non-Current Assets
15.03
15.17
-0.14
-0.92%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
12.90
4.41
8.49
192.52%
Sundry Debtors
9.47
6.31
3.16
50.08%
Cash and Bank
3.42
0.06
3.36
5,600.00%
Other Current Assets
1.77
1.08
0.69
63.89%
Short Term Loans and Advances
5.72
0.70
5.02
717.14%
Total Current Assets
33.28
12.56
20.72
164.97%
Net Current Assets (Including Current Investments)
28.65
7.99
20.66
258.57%
Total Current Assets Excluding Current Investments
33.28
12.56
20.72
164.97%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
48.30
27.73
20.57
74.18%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
1.04
2.57
-1.53
-59.53%
Book Value per share (adjusted)
36.14
16.53
19.61
118.63%
Annual - Borrowings
Borrowings 1.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 79.31% vs -67.42% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.05 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 5.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 66.48% vs 93.51% in Mar 2024
Annual - Investments
Investments 0.68 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 33.28 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.98% vs 58.76% in Mar 2024






